Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cambridge Laboratories acquires U.K. rights to palonosetron

Sep. 9, 2004

Merck researchers develop new macrocyclic BACE inhibitors

Sep. 9, 2004

Novel CGRP antagonists for migraine therapy presented by Boehringer Ingelheim

Sep. 9, 2004

Cymbalta approved for diabetic peripheral neuropathic pain

Sep. 8, 2004

5-HT/norepinephrine reuptake inhibitors and their use in depression, anxiety and pain

Sep. 8, 2004

BIBN-4096BS reveals viability of CGRP receptor antagonism in headache

Sep. 7, 2004

Novel adenosine A2A antagonists and their use in depression, AD, PD, etc.

Sep. 7, 2004

FDA response for Lyrica

Sep. 7, 2004

PTC Therapeutics awarded grant for Duchenne muscular dystrophy research

Sep. 6, 2004

Remoxy cleared to enter U.S. clinical studies

Sep. 6, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...